作者: John C. Bucuvalas , Frederick C. Ryckman
DOI: 10.1034/J.1399-3046.2002.1R058.X
关键词:
摘要: Children (defined as under 18 yr of age) account for approximately 12.5% all liver transplants in the United States. Even though annual number transplantation procedures remains relatively constant, population long-term survivors has grown. Presently, is 10-fold greater then transplantations carried out each year. For transplantation, goal to maintain graft function and wellness while decreasing morbidity associated with immunosuppression. The primary diagnosis leading children do not recur allograft. Consequently, many complications both early long term, relate need may be at increased risk develop significant end-organ damage a result serum lipid levels, elevated blood pressure, altered glucose metabolism, decreased renal function, cancer, diminished bone accretion that occur immunosuppressive therapy or therapy. As survival rates have increased, health care providers begun assess health-related quality life. We will review our current knowledge outcome following pediatric children.